siRNA nanoparticle conjugate solution

0 votes
asked Nov 26, 2021 in H&E by bocsci119 (2,100 points)

The main challenges facing the application of siRNA therapeutics include the stability and effective delivery of siRNA in vivo.

Please log in or register to answer this question.

Welcome to Bioimagingcore Q&A, where you can ask questions and receive answers from other members of the community.